TECH — BIO-TECHNE Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for BIO-TECHNE, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	232	247	204	153	162
Net Total Accounts Receivable
Net Total Receivables	145	195	218	241	207
Total Inventory
Total Other Current Assets
Total Current Assets	511	606	621	617	608
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	282	289	325	342	319
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,263	2,295	2,639	2,704	2,558
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	152	176	129	159	176
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	700	593	672	635	639
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,563	1,702	1,967	2,069	1,919
Total Liabilities & Shareholders' Equity	2,263	2,295	2,639	2,704	2,558
Total Common Shares Outstanding